0001909364-24-000001.txt : 20240503 0001909364-24-000001.hdr.sgml : 20240503 20240503120836 ACCESSION NUMBER: 0001909364-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 EFFECTIVENESS DATE: 20240503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Endeavor Biomedicines, Inc. CENTRAL INDEX KEY: 0001909364 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-512326 FILM NUMBER: 24911767 BUSINESS ADDRESS: STREET 1: 12707 HIGH BLUFF DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 537-1700 MAIL ADDRESS: STREET 1: 12707 HIGH BLUFF DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0708 D LIVE 0001909364 Endeavor Biomedicines, Inc. 12707 High Bluff Drive, Suite 300 San Diego CA CALIFORNIA 92130 (858) 537-1700 DELAWARE None None Corporation true John Hood 12707 High Bluff Dr., Suite 300 San Diego CA CALIFORNIA 92130 Executive Officer Director Miguel de los Rios 12707 High Bluff Dr., Suite 300 San Diego CA CALIFORNIA 92130 Executive Officer Enoch Kariuki 12707 High Bluff Dr., Suite 300 San Diego CA CALIFORNIA 92130 Executive Officer Vishaal Turakhia 12707 High Bluff Dr., Suite 300 San Diego CA CALIFORNIA 92130 Executive Officer Chris Krueger 12707 High Bluff Dr., Suite 300 San Diego CA CALIFORNIA 92130 Executive Officer Bernard Davitian 12707 High Bluff Dr., Suite 300 San Diego CA CALIFORNIA 92130 Director Patrick G. Enright 12707 High Bluff Dr., Suite 300 San Diego CA CALIFORNIA 92130 Director Wing Cheong Lam 12707 High Bluff Dr., Suite 300 San Diego CA CALIFORNIA 92130 Director Monal Mehta 12707 High Bluff Dr., Suite 300 San Diego CA CALIFORNIA 92130 Director Karan Takhar 12707 High Bluff Dr., Suite 300 San Diego CA CALIFORNIA 92130 Director Biotechnology Decline to Disclose 06b false 2024-04-22 false true false 0 132583908 132583908 0 false 32 0 0 0 false Endeavor Biomedicines, Inc. /s/ John Hood John Hood Chief Executive Officer 2024-05-02